July 23, 2018

By: douano@listlabs.com

By: Mary N. Wessling, Ph.D. ELS In this blog we will unravel the terminology describing bacterial toxins. In general, there are at least three ways that bacterial toxins are described in the literature: by their biological designation—the genus and/or species from which they come by the origin of the toxin, either as innate to the […]

January 23, 2018

By: douano@listlabs.com

By: Rachel Berlin, Marketing Manager List Labs is proud to be exhibiting at ASM Biothreats February 12-14th. The conference will be held in Baltimore, Maryland at the Hilton Hotel. Thought leaders in academia, industry and government will gather to present and discuss the latest developments in the emerging field of biothreats. This year’s conference has […]

March 16, 2015

By: List Labs

By: Suzanne Canada, Ph.D. Tanager Medical Writing While you go about your day, you are surrounded by micro-organisms.  Although most of us spend a lot of time washing up and trying not to think about the propensity of creatures that share our personal space, scientists have been studying them.  Due to their great progress, we […]

January 26, 2015

By: List Labs

By: Suzanne Canada, Ph.D. Tanager Medical Writing An exciting report was released in October about a new class of targeted anti-tumor drugs, in which genetically engineered stem cells were used to deliver cytotoxins to brain tumors.1 Brain cancers known as glioblastomas (GBM) are notoriously difficult to treat because the tumors often re-grow after surgery and because […]

March 18, 2014

By: dpinkston@listlabs.com

Shiga Toxins May be Purchased without Government Approval The CDC has removed Shiga toxins (Stx1 and Stx2) from the list of materials requiring oversight.  As a result, Shiga Toxins are no longer classified as select agents and may be purchased without government approval for your research and investigative needs.   While Shiga toxins carry fewer restrictions, […]